Search results for: 'team collaboration'
- Did you mean
- test collaboration
- tech collaboration
- Related search terms
- collaboration technology market analysis 2014
- collaboration technology market analyst 2024
- collaboration technology market analyst 2014
- collaboration technology market analysis 2025
- collaboration technology market analyst 2025
-
10 Sep 2024  |  Global  |  Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...
$4,950.00
Special Price $4,207.50 save 15 %
-
21 Jan 2025  |  Global  |  Technology Research
Technologies Enabling Resilient Pharmaceutical Supply Chains
AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network
This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging tec...
$4,950.00
Special Price $4,207.50 save 15 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare pr...
$4,950.00
Special Price $4,207.50 save 15 %
-
20 Aug 2024  |  Global  |  Technology Research
Technological Advances in Regenerative Medicine
Disruptive Technology and a Competitive Landscape Drive Growth in Stem Cell Therapy Research
Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality. Stem cell research is more focused on induced pluripotent stem cells than on mese...
$4,950.00
Special Price $4,207.50 save 15 %
-
16 Jan 2025  |  Global  |  Technology Research
Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029
The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.
Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...
$4,950.00
Special Price $4,207.50 save 15 %
-
05 Aug 2024  |  Global  |  Technology Research
CGT Research Outlook and Technology Growth Opportunities
CGT Landscape Assessment
The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...
$4,950.00
Special Price $4,207.50 save 15 %